GLUE
Price
$14.32
Change
+$0.16 (+1.13%)
Updated
Nov 13 closing price
Capitalization
933.14M
118 days until earnings call
Intraday BUY SELL Signals
MTVA
Price
$0.66
Change
-$0.05 (-7.04%)
Updated
Nov 13 closing price
Capitalization
16.27M
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs MTVA

Header iconGLUE vs MTVA Comparison
Open Charts GLUE vs MTVABanner chart's image
Monte Rosa Therapeutics
Price$14.32
Change+$0.16 (+1.13%)
Volume$1.02M
Capitalization933.14M
MetaVia
Price$0.66
Change-$0.05 (-7.04%)
Volume$453.61K
Capitalization16.27M
GLUE vs MTVA Comparison Chart in %
GLUE
Daily Signal:
Gain/Loss:
MTVA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLUE vs. MTVA commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and MTVA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (GLUE: $14.16 vs. MTVA: $0.71)
Brand notoriety: GLUE and MTVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 58% vs. MTVA: 17%
Market capitalization -- GLUE: $933.14M vs. MTVA: $16.27M
GLUE [@Biotechnology] is valued at $933.14M. MTVA’s [@Biotechnology] market capitalization is $16.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileMTVA’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • MTVA’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than MTVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 3 TA indicator(s) are bullish while MTVA’s TA Score has 4 bullish TA indicator(s).

  • GLUE’s TA Score: 3 bullish, 4 bearish.
  • MTVA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MTVA is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а +15.03% price change this week, while MTVA (@Biotechnology) price change was -29.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

GLUE is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($933M) has a higher market cap than MTVA($16.3M). GLUE YTD gains are higher at: 104.035 vs. MTVA (-65.202). GLUE has higher annual earnings (EBITDA): 23.3M vs. MTVA (-20.01M). GLUE has more cash in the bank: 291M vs. MTVA (17.6M). MTVA has less debt than GLUE: MTVA (98K) vs GLUE (41.1M). GLUE has higher revenues than MTVA: GLUE (178M) vs MTVA (0).
GLUEMTVAGLUE / MTVA
Capitalization933M16.3M5,724%
EBITDA23.3M-20.01M-116%
Gain YTD104.035-65.202-160%
P/E Ratio44.78N/A-
Revenue178M0-
Total Cash291M17.6M1,653%
Total Debt41.1M98K41,939%
FUNDAMENTALS RATINGS
MTVA: Fundamental Ratings
MTVA
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEMTVA
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
MTVA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUPR0.750.02
+2.71%
Cuprina Holdings (Cayman) Limited
CNO41.640.65
+1.59%
CNO Financial Group
PCG16.810.22
+1.33%
PG&E Corp
ESCA12.670.13
+1.04%
Escalade
AMAL27.89-0.53
-1.86%
Amalgamated Financial Corp

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with IMNM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-1.12%
IMNM - GLUE
46%
Loosely correlated
-0.51%
KYMR - GLUE
44%
Loosely correlated
+0.25%
NRIX - GLUE
43%
Loosely correlated
-5.37%
VYGR - GLUE
40%
Loosely correlated
-0.23%
CCCC - GLUE
40%
Loosely correlated
N/A
More

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with PMVP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then PMVP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
-7.91%
PMVP - MTVA
35%
Loosely correlated
+6.77%
SPRB - MTVA
34%
Loosely correlated
-9.29%
KPRX - MTVA
30%
Poorly correlated
+0.66%
GLUE - MTVA
29%
Poorly correlated
-1.12%
IMTX - MTVA
28%
Poorly correlated
+16.10%
More